Suppliers / Tanaka Kikinzoku Kogyo

Tanaka Kikinzoku Kogyo

Japan Updated 9 July 2026

Tanaka Kikinzoku Kogyo is an API manufacturer based in Japan. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Oxaliplatin US FDA 1

Also appears on these molecule pages

Oxaliplatin API

Questions about Tanaka Kikinzoku Kogyo

Does Tanaka Kikinzoku Kogyo hold a US DMF or a CEP?
Tanaka Kikinzoku Kogyo holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Tanaka Kikinzoku Kogyo make?
1 molecule is on record against Tanaka Kikinzoku Kogyo, including Oxaliplatin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Tanaka Kikinzoku Kogyo comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hetero shares 1 molecule Cipla shares 1 molecule Laurus Labs shares 1 molecule Shilpa Pharma Lifesciences shares 1 molecule Veranova Lp shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability